Results 211 to 220 of about 460,538 (295)

Predicting Loss of Ambulation in Limb Girdle Muscular Dystrophy R9

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Limb girdle muscular dystrophy type R9 (LGMDR9) results from biallelic variants in FKRP. There is limited data to predict loss of ambulation (LOA) among those with LGMDR9. Methods Participants in an ongoing dystroglycanopathy natural history study (NCT00313677) with FKRP variants who had achieved ambulation and were more than 3 ...
Chandra L. Miller, Lauren N. Coffey, Shelley R. H. Mockler, Katie M. Laubscher, Carrie M. Stephan, M. Bridget Zimmerman, Katherine D. Mathews   +6 more
wiley   +1 more source

Correction: Neurologic symptoms following COVID-19 in Lima, Peru: a prospective longitudinal observational study

Frontiers in Neurology
Hanalise V. Huff, Hanalise V. Huff, Carla Villanueva-Colina, Monica M. Diaz, Sofia Tovar, Andrea Davila Luna, Tianxia Wu, Davidson H. Hamer, Davidson H. Hamer, Davidson H. Hamer, Igor J. Koralnik, Tom Solomon, Tom Solomon, Miguela A. Caniza, Patricia J. Garcia   +14 more
doaj   +1 more source

Neurotoxicity of Immunotherapy: Immune Checkpoint Inhibitor-Related Encephalitis vs. Immune Effector Cell-Associated Neurotoxicity Syndrome. [PDF]

World J Oncol
Sato T, Chida K, Gandhi S, Takabe K.
europepmc   +1 more source

Real‐World Performance of CSF Kappa Free Light Chains in the 2024 McDonald Criteria

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Kappa free light chains (KFLCs) in the cerebrospinal fluid (CSF) have a similar performance to CSF‐restricted oligoclonal bands (OCB) for multiple sclerosis (MS) diagnosis. To help with implementation, we set out to resolve several remaining uncertainties: (1) performance in a real‐world cohort and the 2024 McDonald criteria; (2 ...
Maya M. Leibowitz, Ryan Cooper, Stefania Kaninia, Kathryn I. Challis, Will Greenway, Maria Bonello, Mahmoud Elbahnasawi, Deborah T. Shode, Dominika Gajdasik, Victor Iliev, Alison M. E. Whitelegg, Ian Galea   +11 more
wiley   +1 more source

A Large Language Model Workflow for Auditable Brain Abscess Risk Stratification and Pre-residency Scholarship: A Technical Report. [PDF]

Cureus
Akhavan A, Nath S.
europepmc   +1 more source

Immune‐Driven Expression in Inclusion Body Myositis With T‐Cell Large Granular Lymphocytic Leukemia

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objectives T‐cell large granular lymphocytic leukemia (T‐LGLL), reported in up to 58% of inclusion body myositis (IBM) patients, is a rare leukemia of cytotoxic or less commonly helper T cells. The range of myopathies in T‐LGLL and the impact of coexisting T‐LGLL in IBM are not well understood. Our objectives are to investigate the spectrum of
Pannathat Soontrapa, Iago Pinal‐Fernandez, Pritikanta Paul, Michael P. Skolka, Margherita Milone, Min Shi, Mithun V. Shah, Maria Casal‐Dominguez, Katherine Pak, Andrew L. Mammen, Teerin Liewluck   +10 more
wiley   +1 more source

Under a Spell: Neurologic Evaluation of Presyncope as a Feature of Dysautonomia. [PDF]

Biomedicines
Blitshteyn S, Chémali KR, Lau DH.
europepmc   +1 more source

Neurological channelopathies

BMJ, 1998
openaire   +3 more sources

Applying an Ethical Lens to the Treatment of People With Multiple Sclerosis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT The practice of neurology requires an understanding of clinical ethics for decision‐making. In multiple sclerosis (MS) care, there are a wide range of ethical considerations that may arise. These involve shared decision‐making around selection of a disease‐modifying therapy (DMT), risks and benefits of well‐studied medications in comparison to
Methma Udawatta, Farrah J. Mateen
wiley   +1 more source

Initially Normal MRI, Delayed Splenial Lesion in Marchiafava-Bignami Disease. [PDF]

Clin Case Rep
Nojima T, Tanabe R, Obara T, Hongo T, Yumoto T.   +4 more
europepmc   +1 more source